- Home
- IKNA
IKNA
Ikena Oncology Inc.
as 12-24-2024 4:00pm EST
Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. Its targeted oncology product candidate, IK-930, is an oral small-molecule inhibitor of the transcriptional enhanced associate domain, or TEAD, a transcription factor in the Hippo signaling pathway, a known oncogenic pathway that also drives resistance to multiple targeted and chemotherapies. Its other product candidates are IK-175 and IK-595.
| Founded: | 2016 | Country: | United States |
| Employees: | N/A | City: | BOSTON |
| Market Cap: | 74.8M | IPO Year: | 2021 |
| Target Price: | $3.00 | AVG Volume (30 days): | 394.0K |
| Analyst Decision: | Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.24 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.22 - $2.29 | Next Earning Date: | 11-07-2024 |
| Revenue: | $659,000 | Revenue Growth: | -95.28% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Ikena Oncology Inc. News
IKNA Breaking Stock News: Dive into IKNA Ticker-Specific Updates for Smart Investing
TipRanks
2 days ago
Ikena Oncology and Inmagene Announce Merger and Fundraising
MT Newswires
3 days ago
Sector Update: Health Care Stocks Advance Late Afternoon
MT Newswires
3 days ago
Sector Update: Health Care Stocks Advance in Afternoon Trading
MT Newswires
3 days ago
Sector Update: Health Care
MT Newswires
3 days ago
Ikena Oncology, Inmagene Sign Merger Deal; Shares Rise
GlobeNewswire
3 days ago
Ikena Oncology and Inmagene Biopharmaceuticals Announce Agreement for Merger and Private Placement
Simply Wall St.
a month ago
3 US Penny Stocks With Market Caps Over $40M To Consider
Simply Wall St.
2 months ago
Ikena Oncology Third Quarter 2024 Earnings: US$0.21 loss per share (vs US$0.40 loss in 3Q 2023)
Compare IKNA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "IKNA Ikena Oncology Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.